Wednesday - December 31, 2025

Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is gaining investor attention as a next-generation biopharmaceutical company developing advanced immune-strengthening therapeutics for some of the world’s most critical diseases, including HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, and Diabetes. The company’s intellectual … Continue reading

$2 Stocks to Watch Now: CETX, SNYR, AEHL, SURG, SOPA, PNPN.V, MYSE & DRMA – See 2026 Expectations

As investors position for 2026, a growing group of sub-$2 and low-priced stocks is drawing attention for one reason: asymmetric upside. These names trade at compressed valuations, yet each sits in a sector where a single catalyst—revenue acceleration, operational execution, … Continue reading

Stocks Under $1: AMIX, TOON, SOAR, SJ, BNRG, PNPNF, PRSO – Double-Digit 2026 Watchlist

As investors look ahead to 2026, several small- and micro-cap stocks are drawing renewed attention due to sector tailwinds, company-specific catalysts, and evolving strategic narratives. Below is a news-style overview of seven companies that market watchers believe could see double-digit … Continue reading